U.S. market Closed. Opens in 17 hours 3 minutes

BDTX | Black Diamond Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue437.00K3.24M2.22M600.00K47.00KN/AN/A
Gross Profit-437.00K-3.24M-2.22M-600.00K-47.00KN/AN/A
Operating Expenses86.02M92.83M126.87M69.57M29.33M8.90M4.12M
Selling, General & Admin27.11M28.39M30.04M21.36M7.58M1.95M666.00K
Research & Development58.91M64.44M96.83M48.21M21.75M6.95M3.45M
Other Operating ExpensesN/A-354.00K-2.19M-1.72M6.00K-16.00KN/A
Operating Income-86.46M-92.83M-126.87M-69.57M-8.90M-8.90M-4.12M
Other Expenses / Income4.02M3.91M1.28M2.32M-26.35M-31.00K-483.00K
Before Tax Income-82.44M-88.92M-125.60M-67.25M-35.26M-8.93M-4.60M
Income Tax ExpensesN/A-4.40M-2.39M-1.77M5.88M-27.00KN/A
Net Income-82.44M-84.52M-123.20M-65.48M-41.14M-8.93M-4.60M
Interest ExpensesN/A-3.91MN/A1.00KN/AN/A65.00K
Basic Shares Outstanding43.95M36.33M36.19M32.91M35.91M13.95M7.20M
Diluted Shares Outstanding43.95M36.33M36.19M32.91M35.91M13.95M7.20M
EBITDA-86.02M-95.06M-125.60M-67.25M-22.94M-8.87M-4.51M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-82.44M-92.83M-125.60M-67.25M-35.26M-8.96M-4.54M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙